- Press releases

Asceneuron Awarded Grant from The Michael J. Fox Foundation

Asceneuron Awarded Second Grant from The Michael J. Fox Foundation for Accelerated Research into Novel Parkinson’s Disease Therapies

- Press releases

Asceneuron Publishes Preclinical Efficacy Data on ASN90

Asceneuron Publishes Pioneering Preclinical Efficacy Data on its Novel Clinical Molecule ASN90 in Both Alzheimer’s and Parkinson’s Disease Models

- Event

Asceneuron to present at the 2nd BrainFit4Life Symposium

Asceneuron will present at the 2nd virtual Symposium organized by BrainFit4Life on November 30th, 2021 from 3pm to 7:30pm CET (9am to 1:30pm EST).

- Press releases

Asceneuron to Provide Update on O-GlcNAcase Pipeline

Asceneuron to Provide Update on O-GlcNAcase Pipeline at Upcoming Conferences

- News

WHO report on the public health response to dementia

The World Health Organization has published a "Global status report on the public health response to dementia" where it takes stock of actions driven by Member States, WHO and civil society since the adoption of the global action plan, identifies barriers to its implementation especially in light of the COVID-19 pandemic, and highlights areas where urgent, accelerated action is required.

- Event

Asceneuron to present at ANA21 virtual meeting

Asceneuron will present at the next ANA21 virtual meeting organized by the American Neurological Association on October 17-19, 2021.

- Event

International Conference on Alzheimer's Drug Discovery

Asceneuron to present at the 22nd International Conference on Alzheimer’s Drug Discovery be held online October 4-5, 2021.

- News

A brighter future for Alzheimer's?

Asceneuron’s unique approach to treat Alzheimer’s disease featured by our CEO Dirk Beher in series of interviews with industry leaders on the future of Alzheimer's disease drug development.

- Press releases

Asceneuron CEO Dirk Beher to speak at AAIC 2021

Asceneuron CEO Dirk Beher to speak at Alzheimer’s Association International Conference

- Press releases

Asceneuron Appoints Catherine Moukheibir to its Board of Directors

Asceneuron Appoints Prominent Healthcare Leader Catherine Moukheibir to its Board of Directors